United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

sandoz ltd - ceftazidime pentahydrate - powder for solution for injection - 1gram

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

sandoz ltd - ceftazidime pentahydrate - powder for solution for injection - 500mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

sandoz ltd - ceftazidime pentahydrate - powder for solution for injection - 3gram

Ireland - English - HPRA (Health Products Regulatory Authority)

sandoz pharmaceuticals d.d. - ceftazidime - powder for solution for injection - third-generation cephalosporins; ceftazidime

United Kingdom - English - myHealthbox

glaxo operations uk ltd - ceftazidime - powder for solution for injection or infusion - 2g - anti-bacterials for systemic use. third-generation cephalosporins - it is indicated for the treatment of the infections listed below in adults and children including neonates (from birth). • nosocomial pneumonia • broncho-pulmonary infections in cystic fibrosis • bacterial meningitis • chronic suppurative otitis media • malignant otitis externa • complicated urinary tract infections • complicated skin and soft tissue infections • complicated intra-abdominal infections • bone and joint infections • peritonitis associated with dialysis in patients on capd.

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

glaxosmithkline uk ltd - ceftazidime pentahydrate - powder for solution for injection - 250mg

Israel - English - Ministry of Health

novartis israel ltd., israel - ceftazidime as pentahydrate - powder for solution for inj/inf - ceftazidime as pentahydrate 2 g/vial - ceftazidime - ceftazidime - fortum is indicated for the treatment of the infections listed below in adults and children including neonates (from birth).• nosocomial pneumonia• broncho-pulmonary infections in cystic fibrosis• bacterial meningitis• chronic suppurative otitis media• malignant otitis externa• complicated urinary tract infections• complicated skin and soft tissue infections• complicated intra-abdominal infections• bone and joint infections• peritonitis associated with dialysis in patient on capd.treatment of patients with bacteraemia that occurs in association with, or is suspected to be associated with, any of the infections listed above.ceftazidime may be used in the management of neutropenic patients with fever that is suspected to be due to a bacterial infection.ceftazidime may be used in the peri-operative prophylaxis of urinary tract infections for patients undergoing trans-urethral resection of the prostate (turp).the selection of ceftazidime should take into account its antibacterial spectrum, which is mainly restricted to aerobic gram negative bacteria.ceftazidime should be co-administered with other antibacterial agents whenever the possible range of causive bacteria would not fall within its spectrum of activity.consideration should be given to official guidelines on the appropriate use of antibacterial agents.

New Zealand - English - Medsafe (Medicines Safety Authority)

glaxosmithkline nz limited - ceftazidime pentahydrate 2 g - powder for injection - 2 g - active: ceftazidime pentahydrate 2 g excipient: sodium carbonate - treatment of single or multiple infections caused by susceptible organisms. may be used alone as first choice medicine before the results of sensitivity tests are available. may be used in combination with an aminoglycoside or most other ?- lactam antibiotics. may be used with an antibiotic against anaerobes when the presence of bacteroides fragilis is suspected.

Singapore - English - HSA (Health Sciences Authority)

glaxosmithkline pte ltd - ceftazidime pentahydrate eqv ceftazidime - injection, powder, for solution - 2 g/vial - ceftazidime pentahydrate eqv ceftazidime 2 g/vial

Israel - English - Ministry of Health

novartis israel ltd., israel - ceftazidime as pentahydrate - powder for solution for inj/inf - ceftazidime as pentahydrate 1 g/vial - ceftazidime - ceftazidime - fortum is indicated for the treatment of the infections listed below in adults and children including neonates (from birth).• nosocomial pneumonia• broncho-pulmonary infections in cystic fibrosis• bacterial meningitis• chronic suppurative otitis media• malignant otitis externa• complicated urinary tract infections• complicated skin and soft tissue infections• complicated intra-abdominal infections• bone and joint infections• peritonitis associated with dialysis in patient on capd.treatment of patients with bacteraemia that occurs in association with, or is suspected to be associated with, any of the infections listed above.ceftazidime may be used in the management of neutropenic patients with fever that is suspected to be due to a bacterial infection.ceftazidime may be used in the peri-operative prophylaxis of urinary tract infections for patients undergoing trans-urethral resection of the prostate (turp).the selection of ceftazidime should take into account its antibacterial spectrum, which is mainly restricted to aerobic gram negative bacteria.ceftazidime should be co-administered with other antibacterial agents whenever the possible range of causive bacteria would not fall within its spectrum of activity.consideration should be given to official guidelines on the appropriate use of antibacterial agents.